Sartorius AG ST buy Guggenheim
Start price
24.12.24
/
50%
€176.20
Target price
24.12.25
-
Performance (%)
-1.93%
Price
15.07.25
€172.80
Summary
This prediction is currently active. With a performance of -1.93%, the BUY prediction for Sartorius AG ST by Guggenheim is down slightly. This prediction currently runs until 24.12.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionSartorius is a German-based biotech and laboratory equipment company that is listed on the Frankfurt Stock Exchange under the symbol SARTF. The company provides products and services for the pharmaceutical, biotech, and food industries, including laboratory instruments, consumables, and services. Sartorius has a global presence with operations in Europe, Asia, and the Americas, and has a strong reputation for innovation, quality, and reliability. The company's stock has performed well in recent years, reflecting its solid financial results and growth prospects in the life sciences industry.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius AG ST | -3.464% | -3.464% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by Guggenheim for this prediction
In the thread Discuss Sartorius AG
Sartorius Aktiengesellschaft (OTCMKTS: SARTF) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Ratings data for SARTF provided by MarketBeat